Compounds > nicardipine

nicardipine and cilnidipine

nicardipine has been researched along with cilnidipine in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (23.08)18.2507
2000's5 (38.46)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reimão, JQ; Scotti, MT; Tempone, AG1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B1
Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A1
Chen, GF; Hashitani, H; Kou, M; Kuriyama, H; Nakashima, M; Ono, H; Suzuki, H1
Dohmoto, H; Goto, A; Yamada, K; Yoshimoto, R1
Dozen, M; Hayashi, Y; Hosono, M; Watanabe, K1
Esashi, A; Fujii, S; Hosono, M; Hozumi, S; Kisara, K; Kitamura, K; Murakami, M; Nakagawasai, O; Okamura, T; Sasano, H; Suzuki, T; Tadano, T; Tan-no, K; Taniguchi, R; Yanagisawa, T1
Ando, K; Hashimoto, K; Nakamura, Y; Satoh, Y; Sugiyama, A; Takahara, A1
Daitoku, K; Furukawa, K; Motomura, S; Seya, K1
Asano, S; Fuke, N; Ide, F; Matsuno, A; Miyawaki, S; Murakami, M; Nakaguchi, H; Sasaki, M; Tanaka, H; Tanaka, J; Uno, T1
Hasegawa, H; Iino, K; Ishida, M; Ito, H; Kosaka, T; Nakagawa, M; Watanabe, H1
Ando, K; Cao, X; Izumi-Nakaseko, H; Nakamura, Y; Saitoh, M; Sugiyama, A; Takahara, A; Wada, T; Xu, B; Zhu, B1
Kume, K; Ohsawa, M; Ono, H; Suzuki, Y; Yamamoto, S1

Trials

1 trial(s) available for nicardipine and cilnidipine

ArticleYear
Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease.
    Journal of cardiology, 2009, Volume: 54, Issue:2

    Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nicardipine; Prospective Studies; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left

2009

Other Studies

12 other study(ies) available for nicardipine and cilnidipine

ArticleYear
Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.
    Bioorganic & medicinal chemistry, 2010, Nov-15, Volume: 18, Issue:22

    Topics: Animals; Antiprotozoal Agents; Cell Line; Cricetinae; Dihydropyridines; Erythrocytes; Leishmania; Macaca mulatta; Mice; Parasitic Sensitivity Tests; Quantitative Structure-Activity Relationship; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi

2010
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10

    Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers

2012
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bioorganic & medicinal chemistry letters, 2012, Dec-15, Volume: 22, Issue:24

    Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity

2012
Actions of FRC-8653 on smooth muscle cells of the rabbit mesenteric artery.
    Japanese journal of pharmacology, 1991, Volume: 57, Issue:1

    Topics: Animals; Antihypertensive Agents; Biomechanical Phenomena; Calcium Channel Blockers; Dihydropyridines; Electric Stimulation; Endothelium, Vascular; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Nicardipine; Rabbits; Sympathetic Nervous System; Synaptic Transmission

1991
Prolonged inhibition of vascular contraction and calcium influx by the novel 1,4-dihydropyridine calcium antagonist cinaldipine (FRC-8653).
    Japanese journal of pharmacology, 1991, Volume: 56, Issue:2

    Topics: Animals; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Dihydropyridines; In Vitro Techniques; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains; Time Factors; Vasodilator Agents

1991
[Effect of cilnidipine on renal function in SHR and endothelin-induced renal dysfunction].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 107, Issue:2

    Topics: Acute Kidney Injury; Animals; Calcium Channel Blockers; Dihydropyridines; Diuresis; Endothelins; Hypertension; Male; Natriuresis; Nicardipine; Nifedipine; Rats; Rats, Inbred SHR; Renal Circulation

1996
Antinociceptive effect of cilnidipine, a novel N-type calcium channel antagonist.
    Brain research, 2000, Jun-16, Volume: 868, Issue:1

    Topics: Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression; In Situ Hybridization; Mice; Mice, Inbred C57BL; Nicardipine; Nociceptors; RNA, Messenger; Synaptic Transmission

2000
Comparison of the direct negative dromotropic effect of a new calcium channel blocker, cilnidipine, with that of nicardipine.
    Heart and vessels, 2005, Volume: 20, Issue:3

    Topics: Aged; Analysis of Variance; Animals; Atrial Fibrillation; Bradycardia; Calcium Channel Blockers; Dihydropyridines; Dogs; Electrocardiography; Female; Humans; Hypertension; Nicardipine

2005
Assessment of the effects of L- and N-type Ca2+ channel blocking drugs using canine blood-perfused papillary muscle preparations.
    The Tohoku journal of experimental medicine, 2007, Volume: 212, Issue:4

    Topics: Adrenergic alpha-Agonists; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Microdialysis; Muscle Contraction; Myocardium; Nicardipine; Norepinephrine; omega-Conotoxin GVIA; Papillary Muscles

2007
Oral administration of cilnidipine to patients with hypertensive intracerebral hemorrhage in the acute stage: significance and role of an N-type calcium channel blocker.
    Irish journal of medical science, 2009, Volume: 178, Issue:4

    Topics: Acute Disease; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Female; Hematoma; Humans; Intracranial Hemorrhage, Hypertensive; Male; Middle Aged; Nicardipine; Treatment Outcome

2009
Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
    Heart and vessels, 2016, Volume: 31, Issue:12

    Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Coronary Vasospasm; Coronary Vessels; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Male; Nicardipine; Nifedipine; Rats; Time Factors; Vasoconstriction; Vasodilator Agents; Vasopressins

2016
N- and L-type calcium channels blocker cilnidipine ameliorates neuropathic pain.
    European journal of pharmacology, 2016, Dec-15, Volume: 793

    Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Conotoxins; Dihydropyridines; Evoked Potentials; Long-Term Potentiation; Male; Mice; Nerve Fibers, Unmyelinated; Neuralgia; Nicardipine; Rats; Spinal Cord Dorsal Horn

2016